首页> 美国卫生研究院文献>Infection and Immunity >Serum Opacity Factor (SOF) of Streptococcus pyogenes Evokes Antibodies That Opsonize Homologous and Heterologous SOF-Positive Serotypes of Group A Streptococci
【2h】

Serum Opacity Factor (SOF) of Streptococcus pyogenes Evokes Antibodies That Opsonize Homologous and Heterologous SOF-Positive Serotypes of Group A Streptococci

机译:化脓性链球菌的血清不透明因子(SOF)引起与A组链球菌的同源和异源SOF阳性血清型调理的抗体

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Serum opacity factor (SOF) is a protein expressed by Streptococcus pyogenes that opacifies mammalian serum. SOF is also a virulence factor of S. pyogenes, but it has not been previously shown to elicit a protective immune response. Herein, we report that SOF evokes bactericidal antibodies against S. pyogenes in humans, rabbits, and mice. Rabbit antiserum against purified recombinant SOF2 opsonized SOF-positive M type 2, 4, and 28 S. pyogenes in human blood but had no effect on SOF-negative M type 5 S. pyogenes. Furthermore, affinity-purified human antibodies against SOF2 also opsonized SOF-positive streptococci. A combination of antisera against M2 and SOF2 proteins was dramatically more effective in killing streptococci than either antiserum alone, indicating that antibodies against SOF2 enhance the opsonic efficiency of M protein antibodies. Mice tolerated an intravenous injection of 100 μg of SOF without overt signs of toxicity, and immunization with SOF protected mice against challenge infections with M type 2 S. pyogenes. These data indicate that SOF evokes opsonic antibodies that may protect against infections by SOF-positive serotypes of group A streptococci and suggest that different serotypes of SOF have common epitopes that may be useful vaccine candidates to protect against group A streptococcal infections.
机译:血清不透明因子(SOF)是化脓性链球菌表达的一种蛋白,可以使哺乳动物的血清不透明。 SOF还是化脓性链球菌的毒力因子,但以前尚未证明它会引起保护性免疫反应。在本文中,我们报道SOF在人,兔和小鼠中引起针对化脓性链球菌的杀菌抗体。兔抗纯化的重组SOF2血清对人血中SOF阳性的M型2、4和28化脓性链球菌进行调理,但对SOF阴性的M型5化脓性链球菌无效。此外,亲和纯化的针对SOF2的人抗体也调理SOF阳性链球菌。抗M2和SOF2蛋白的抗血清的组合比单独使用任何一种抗血清,在杀死链球菌方面更有效,这表明抗SOF2的抗体增强了M蛋白抗体的调理作用。小鼠耐受100μgSOF的静脉注射而没有明显的毒性迹象,并且用SOF免疫可以保护小鼠免受M型2化脓性链球菌感染的攻击。这些数据表明,SOF唤起了可以预防A组链球菌SOF阳性血清型感染的调理抗体,并表明SOF的不同血清型具有共同的表位,可能是预防A组链球菌感染的有用候选疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号